Sales of High-flow Nasal Cannula to Concentrate in North America, Enabling Overall Growth at 11.8% CAGR through 2025: Fact.MR
30 Jun 2022
AcquisitionCollaborate
Acute Respiratory Failures Segment to Leverage the Market Growth, Accounting for 3/10 of the Total High-flow Nasal Cannula Sales
In its latest study on the high-flow nasal cannula market, Fact.MR provides insights into factors propelling the demand across various segments in terms of component, application, and end user. The report also shed light on critical trends and opportunities elevating growth prospects for the high-flow nasal cannula market for the assessment period.
Fact.MR, Dubai: As per an exhaustive survey conducted by Fact.MR, the global high-flow nasal cannula market size is expected to double, surpassing US$ 9 Bn by the end of 2025. Increasing application of high-flow nasal cannula across hospitals, tomosynthesis, ambulatory care centers, and others is fueling the demand in the market.
Rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), bronchiectasis, acute respiratory failures, and others is majorly underpinning the demand in the market. According to the World Health Organization, nearly 3.23 million fatalities were reported across the globe due to COPD, making it the 3rd leading cause of death.
As high-flow nasal cannula are extensively used for providing oxygenation support and reducing respiratory rate amongst patients, rising prevalence of aforementioned diseases is expected to assist the market to grow at 11.8% CAGR over the forecast period 2020-2025.
As per Fact.MR, North America is projected to dominate the high-flow nasal cannula market, accounting for over 2/5th of the total sales through 2025. Growing shift in patient preference towards continuous positive airway pressure (CPAP) and non-invasive ventilation (NIV) devices in homecare settings across countries such as the U.S. and Canada is favoring the growth in the region.
Request A Report Sample to Gain Comprehensive Insights
Based on applications, the acute respiratory failures segment is anticipated to account for 3/10th of the market share, expanding at 11.4% CAGR through 2025. Increasing use in alleviating upper airway obstruction amongst patients with acute respiratory failures is propelling the demand in the segment.
“Growing acceptance of high-flow nasal cannula among patients and increasing government emphasis on preventing, managing and treating pulmonary disorders & infections is expected to generate immense growth prospects in the market,” says a Fact.MR analyst.
Key Takeaways from the High-Flow Nasal Cannula Market Study
The U.S. is anticipated to lead the market in North America, due to the increasing burden of respiratory diseases in the country.
The U.K. is projected to account for a significant share in Europe market, owing to increasing emphasis on the prevention and treatment of respiratory diseases.
Sales in China are expected to rise at a rapid pace, assisting the Asia Pacific market to expand at a staggering CAGR of 13.2% through 2025.
On the basis of component, the active humidifiers are forecast to register steady growth in the market, accounting for more than 1/4th of the sales by 2025.
The sleep apnea segment is estimated to be the fastest growth in the market, expanding at 13.5% CAGR over the assessment period.
Key Drivers
Rapidly increasing burden of respiratory ailments across China and India, owing to growing smoker percentage, rising air pollution, and changing climatic conditions is expected to favor the growth in Asia Pacific high-flow nasal cannula market.
Increasing use of high-flow nasal cannula for providing a consistent flow of humidified oxygen supply during high-flow oxygen therapy for the treatment of sleep apnea is propelling the demand across the sleep apnea segment.
Key Restraints
High cost of high-flow nasal cannulas as compared to the conventional nasal cannula is hampering the growth in the market.
Adverse effects associated with the use of high-flow nasal cannulas such as nasal dryness, pulmonary oxygen toxicity, eye damage, and lung damage are hindering the sales in the market.
Get Customize Report As Per Your Needs!
Competitive Landscape
As per Fact.MR, top four companies in the global high-flow nasal cannula market are Fisher & Paykel Healthcare Limited, BD/CareFusion, ResMed Inc., and Telefax incorporated. These manufacturers are estimated to collectively account for 3/10th of the total sales in the market.
Leading players are focusing on development and launch of novel products to enhance their products portfolio. Apart from this, some of the players are aiming at expanding their production capacity to address the surging demand. For instance,
In January 2021, Vadi Medical Technology, a leading manufacturer of medical devices, announced expanding its existing range of humidifiers by launching a new product – VH3000-220 Humidifier. This launch will assist the company to strengthen its footprint in the market.
In June 2020, Fisher & Paykel Healthcare, a New Zealand-based medical appliance manufacturer, announced accelerating its production of ventilators and other humidification and respiratory support products to address the demand during the COVID-19 pandemic.
Some of the key players in the market profiled by Fact.MR are:
Allied Healthcare Products, Inc.
Vapotherm Ltd.
Fisher & Paykel Healthcare Limited
Becton
Dickinson and Company
ResMed Ltd. T
Teleflex Incorporated
Flexicare Medical Ltd.
Vapotherm Inc.
ResMed Inc.
Fairmont Medical
Well Lead Medical Co. Ltd.
More Valuable Insights on High-flow Nasal Cannula Market
A recent survey by Fact.MR offers a detailed analysis on the global high-flow nasal cannula market, analyzing forecast statistics for the assessment period 2020-2025. The study offers refines sales projections in high-flow nasal cannula market with detailed segmentation:
Component
Air/Oxygen Blend
Air Humidifier
Single Heated Tube
Nasal Cannula
Other Consumables
Application
Acute Respiratory Failure
Chronic Obstructive Pulmonary Disease (COPD)
Carbon Monoxide Toxicity
Bronchiectasis
Sleep Apnea
Acute Respiratory Failure
Other Applications
End-user
Hospitals
Long-term Care Centers
Ambulatory Care Centers
Tomosynthesis
Other End-users
Key Regions
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Key Questions Covered in the High-flow Nasal Cannula Market Report
The market survey also highlights projected sales growth of the high-flow nasal cannula market between 2020 and 2025
The report offers insight into high-flow nasal cannula demand outlook for 2020-2025
High-flow nasal cannula market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others
High-flow nasal cannula market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
Explore Fact.MR’s Coverage on the Healthcare Domain
3D Printing Medical Devices Market: Fact.MR projects the 3D printing medical devices market is expected to witness exhibiting growth at 10.9% CAGR during 2022-2032 in comparison to a CAGR of 14.5% with which it grew from 2017 to 2021.
Medical Device Technologies Market: According to Fact.MR, United States is likely to maintain its leadership position in the medical device technologies industry, forecast to expand at a 5.8% value CAGR. It is expected that the area would account for roughly 40% of the worldwide market value.
Medical Device Coating Market: Growing patient inclination toward minimally invasive procedures and increasing adoption of implantable devices for the treatment of several medical conditions is favoring the growth in the market. This is estimated to accelerate the demand for medical device coatings at a CAGR of 6.7% during the forecast period.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-158
Follow Us: LinkedIn | Twitter
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.